← All stocks

RIGEL PHARMACEUTICALS INC

RIGL Scheduled selling only

CIK 0001034842 #2685 in the set updated 20 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$305.87K

$160.43K on a plan · $145.44K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$305.87K

$0.00 against sales at will

By person

12 insiders · 14 transactions

12.1×

Raul R. Rodriguez holds 12.1 times base salary in stock. $9.57M of shares against $787.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Raul R. Rodriguez last reported holding, valued at $35.00, the price Common Stock was last bought or sold at on the open market here, on 22 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ali-Jackson Kamil

Director

—

$160.43K (2) scheduled

−$160.43K

10,125

0.0542%

$354.38K

+47.3%

MOOS WALTER H

Director

—

$145.44K (1) scheduled

−$145.44K

18,472

0.0989%

$646.52K

+80.7%

RODRIGUEZ RAUL R

CEO, President

—

273,362

1.46%

$9.57M

+35.4%

Schorno Dean L

EVP & Chief Financial Officer

—

82,962

0.4441%

$2.90M

+93.9%

Santos David A

EVP, Chief Commercial Officer

—

61,622

0.3299%

$2.16M

+64.7%

Furey Raymond J.

EVP, GC, CCO & Corp Sec

—

50,559

0.2707%

$1.77M

+116.1%

HANNAH ALISON L.

EVP, Chief Medical Officer

—

35,025

0.1875%

$1.23M

+1,375%

Rojkjaer Lisa

EVP, Chief Medical Officer

—

34,003

0.1820%

$1.19M

—

Wasman Jane

Director

—

18,250

0.0977%

$638.75K

+82.5%

LAPOINTE ANTHONY GREGG

Director

—

18,250

0.0977%

$638.75K

+82.5%

Frohlich Mark W

Director

—

7,000

0.0375%

$245.00K

—

MILLER MICHAEL PATRICK

Director

—

5,937

0.0318%

$207.80K

+3,075%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Schorno Dean L

2 Sep 2026

EVP & Chief Financial Officer

Exercised, kept

1,286

$24.20

$31.12K

Schorno Dean L

2 Sep 2026

EVP & Chief Financial Officer

Exercised, kept

2,000

$24.20

$48.40K

Schorno Dean L

2 Sep 2026

EVP & Chief Financial Officer

Exercised, kept

620

$18.70

$11.59K

Schorno Dean L

2 Sep 2026

EVP & Chief Financial Officer

Exercised, kept

694

$12.70

$8.81K

Schorno Dean L

1 Jun 2026

EVP & Chief Financial Officer

Exercised, kept

2,181

$12.70

$27.70K

Schorno Dean L

1 Jun 2026

EVP & Chief Financial Officer

Exercised, kept

1,200

$18.70

$22.44K

RODRIGUEZ RAUL R

26 Jan 2026

CEO, President

Exercised, kept

40,000

$27.40

$1.10M

RODRIGUEZ RAUL R

26 Jan 2026

CEO, President

Exercised, kept

40,000

$27.40

$1.10M

Schorno Dean L

22 Dec 2025

EVP & Chief Financial Officer

Exercised, kept

1,667

$18.70

$31.17K

Schorno Dean L

22 Dec 2025

EVP & Chief Financial Officer

Exercised, kept

2,846

$24.20

$68.87K

Schorno Dean L

22 Dec 2025

EVP & Chief Financial Officer

Exercised, kept

1,987

$20.00

$39.74K

Show all 14 transactions →

What was left out

Form 4 filings counted 41

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 428,481

History held since 1 Sep 2016